Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Acquired central diabetes insipidus (acquired CDI) is a subtype of central diabetes insipidus (CDI), characterized by polyuria and polydipsia, due to an idiopathic or secondary decrease in vasopressin (AVP) production.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for acquired central diabetes insipidus.
13 publications have been identified in PubMed for acquired central diabetes insipidus. Research spans Review / Meta-Analysis (38%), Epidemiology / Natural History (38%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 5 | 38% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acquired central diabetes insipidus
Disease patterns and progression
5 |
38% |
Patient case studies | 2 | 15% |
Clinical study results | 1 | 8% |
Vijayan M (2026). [PMID: 41668460](https://pubmed.ncbi.nlm.nih.gov/41668460/). *Endocrinology*. [Review / Meta-Analysis]
Kosaka T (2026). [PMID: 40467512](https://pubmed.ncbi.nlm.nih.gov/40467512/). *Intern Med*. [Review / Meta-Analysis]
Chien MM (2025). [PMID: 38631957](https://pubmed.ncbi.nlm.nih.gov/38631957/). *J Formos Med Assoc*. [Epidemiology / Natural History]
Xaplanteri P (2025). [PMID: 40429858](https://pubmed.ncbi.nlm.nih.gov/40429858/). *Int J Mol Sci*. [Review / Meta-Analysis]
Tarka P (2025). [PMID: 40725595](https://pubmed.ncbi.nlm.nih.gov/40725595/). *J Clin Med*. [Epidemiology / Natural History]
Damani N (2025). [PMID: 41180590](https://pubmed.ncbi.nlm.nih.gov/41180590/). *J Infect Prev*. [Review / Meta-Analysis]
Akorful RAA (2025). [PMID: 40277958](https://pubmed.ncbi.nlm.nih.gov/40277958/). *Infect Dis Rep*. [Review / Meta-Analysis]
Mori N (2025). [PMID: 39914651](https://pubmed.ncbi.nlm.nih.gov/39914651/). *J Infect Chemother*. [Epidemiology / Natural History]
Spigaglia P (2025). [PMID: 39790071](https://pubmed.ncbi.nlm.nih.gov/39790071/). *Euro Surveill*. [Clinical Trial Publication]
Alland SE (2025). [PMID: 40927238](https://pubmed.ncbi.nlm.nih.gov/40927238/). *Antimicrob Steward Healthc Epidemiol*. [Epidemiology / Natural History]